ConductScience.org, home

Paper40607289

Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study.

Shiratori F and 16 others. Ann Gastroenterol Surg, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study. Papers, record 40607289. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40607289

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study.
PubMed
Journal
Ann Gastroenterol Surg
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-09-25
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shiratori FFumiakihttps://orcid.org/0000-0003-2864-5890
2Fujiwara NNaoto
3Nakajima YYasuaki
4Otsuka KKoji
5Murakami MMasahiko
6Matsuda SSatoruhttps://orcid.org/0000-0001-8441-2755
7Kawakubo HHirofumihttps://orcid.org/0000-0002-4929-5482
8Takahashi KKeitahttps://orcid.org/0000-0003-0149-3401
9Tanishima YYuichirohttps://orcid.org/0000-0003-3040-5992
10Oka DDaiji
11Ito SShunichihttps://orcid.org/0000-0002-8850-4566
12Narumiya KKosuke
13Aramaki OOsamu
14Takayama TTadatoshi
15Suzuki TTakashi
16Yajima SSatoshi
17Shimada HHideakihttps://orcid.org/0000-0002-1990-8217

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130003189p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma.Ann Gastroenterol Surg2018https://conductscience.org/library/papers/30003189PubMed
233363728Possible predictive significance of serum RalA autoantibodies on relapse-free survival in patients with colorectal cancer.Mol Clin Oncol2021https://conductscience.org/library/papers/33363728PubMed
335429246Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.Cancer Immunol Immunother2022https://conductscience.org/library/papers/35429246PubMed
417855703The impact of autoimmune diseases on the incidence and prognosis of cutaneous malignant melanoma.Cancer Epidemiol Biomarkers Prev2007https://conductscience.org/library/papers/17855703PubMed
534632560Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers.Int J Clin Oncol2022https://conductscience.org/library/papers/34632560PubMed
640607289Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study.Ann Gastroenterol Surg2025https://conductscience.org/library/papers/40607289PubMed
730950146Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma.Cancer Sci2019https://conductscience.org/library/papers/30950146PubMed
831535225Recent progress in multidisciplinary treatment for patients with esophageal cancer.Surg Today2020https://conductscience.org/library/papers/31535225PubMed
928064445Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer.Cancer Sci2017https://conductscience.org/library/papers/28064445PubMed
1032458231Serum p53 antibody: useful for detecting gastric cancer but not for predicting prognosis after surgery.Surg Today2020https://conductscience.org/library/papers/32458231PubMed
1127110229Comprehensive Registry of Esophageal Cancer in Japan, 2009.Esophagus2016https://conductscience.org/library/papers/27110229PubMed
1211042560Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.Cancer2000https://conductscience.org/library/papers/11042560PubMed
1315383868Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients.World J Surg2004https://conductscience.org/library/papers/15383868PubMed
1429691673Multi-panel assay of serum autoantibodies in colorectal cancer.Int J Clin Oncol2018https://conductscience.org/library/papers/29691673PubMed
1525906289NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers.J Gastroenterol2016https://conductscience.org/library/papers/25906289PubMed
1632490341Prognostic impact of p53 and/or NY-ESO-1 autoantibody induction in patients with gastroenterological cancers.Ann Gastroenterol Surg2020https://conductscience.org/library/papers/32490341PubMed
1730150518A Multicenter Study to Assess EGFR Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical Setting.Cancers (Basel)2018https://conductscience.org/library/papers/30150518PubMed
1827553002A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer.Cancer Immunol Immunother2016https://conductscience.org/library/papers/27553002PubMed
1932574375Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study.Int J Cancer2020https://conductscience.org/library/papers/32574375PubMed
2023208313Investigation of the freely available easy-to-use software 'EZR' for medical statistics.Bone Marrow Transplant2013https://conductscience.org/library/papers/23208313PubMed

See all 24 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42220520Tumor antigen-associated autoantibodies: generation mechanisms, roles in tumorigenesis and progression, and clinical application prospects.Front Immunol2026https://conductscience.org/library/papers/42220520PubMed
41971943Computational Approach Improves Diagnostic Performance Based on Tumor-Associated Autoantibodies in Esophageal Squamous Cell Carcinoma.Comput Struct Biotechnol J2026https://conductscience.org/library/papers/41971943PubMed
40607289Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study.Ann Gastroenterol Surg2025https://conductscience.org/library/papers/40607289PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CTAG1A246100PubTator's text mininghttps://conductscience.org/library/genes/246100NCBI Gene
EIF110209PubTator's text mininghttps://conductscience.org/library/genes/10209NCBI Gene
MYC4609PubTator's text mininghttps://conductscience.org/library/genes/4609NCBI Gene
NUP6223636PubTator's text mininghttps://conductscience.org/library/genes/23636NCBI Gene
RALA5898PubTator's text mininghttps://conductscience.org/library/genes/5898NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40607289

GET https://conductscience.org/api/papers/v1/40607289/references?page=2